Top Markets
#1 Seeker Seeker +17.21%
#2 Official Trump Official Trump +12.94%
#3 DeFi Kingdoms DeFi Kingdoms +10.56%
#4 EXOD EXOD +9.04%
#5 Wrapped Aave Ethereum WETH Wrapped Aave Ethereum WETH +8.10%
#6 peaq peaq +7.28%
#7 Ethena Staked ENA Ethena Staked ENA +6.55%
#8 TDCCP TDCCP +5.86%
#9 Melania Meme Melania Meme +5.55%
#10 Stacks Stacks +5.26%
Coin of the day
Seeker Seeker
설정
언어
한국어
통화
USD
테마
Taysha Gene Therapies, Inc. Taysha Gene Therapies, Inc.

Taysha Gene Therapies, Inc.

TSHA
주식 순위 #6652
Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and... Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and market introduction of gene therapies that utilize adeno-associated virus (AAV) vectors. Its core mission is to tackle inherited diseases affecting the central nervous system (CNS). The company's development pipeline features several key programs: TSHA-120 is aimed at giant axonal neuropathy; TSHA-102 is in development for Rett syndrome; TSHA-121 and TSHA-118 are both being advanced for CLN1 disease; TSHA-105 addresses SLC13A5 Deficiency; and TSHA-101 targets GM2 gangliosidosis. Furthermore, Taysha has forged a strategic alliance with The University of Texas Southwestern Medical Center to jointly advance and bring to market innovative gene therapy solutions. Founded in 2019, the company operates from its headquarters in Dallas, Texas.
주가
$6.02
마지막 동기화: 2026-08-27
시가총액
$1.93B
변동 (1일)
0.00%
변동 (1년)
112.72%
국가
US
거래 Taysha Gene Therapies, Inc. (TSHA)

카테고리

Healthcare
Taysha Gene Therapies, Inc. (TSHA)의 배당 수익률 기록
Taysha Gene Therapies, Inc. (주식 심볼: TSHA)의 배당 수익률 (TTM)은 2026 기준으로 0입니다.
지난 5년 평균 배당 수익률: 0.00%
Taysha Gene Therapies, Inc. (TSHA)의 배당 수익률 기록: 2026 ~ 2026
연도별 말 기준 배당 수익률 (TTM)
연도 배당 수익률 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 배당 수익률 (TTM)
회사 배당 수익률 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH